Back
Vertex Pharmaceuticals Stock Predictions
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Sell
41
VRTX
Vertex Pharmaceuticals
Last Price:
$422.14
Seasonality Move:
-3.66%
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]Vertex Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Vertex Pharmaceuticals has on average historically risen by 24.4% based on the past 33 years of stock performance.
-
Vertex Pharmaceuticals has risen higher in 19 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.58%
-
Is Vertex Pharmaceuticals Stock Undervalued?The current Vertex Pharmaceuticals [VRTX] share price is $422.00. The Score for VRTX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Vertex Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Vertex Pharmaceuticals has on average historically risen by 24.4% based on the past 33 years of stock performance.
Vertex Pharmaceuticals Stock Rating
Sell
41
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals overpriced?
-
Vertex Pharmaceuticals has risen higher in 19 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.58%
Vertex Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vrtx.com
52-Week Data
52-Week High:
519.88
52-Week Low:
377.85
Prediction Charts
Market Cap:
108.7B
Price in USD:
422.00
Volume:
1.7M
Beta:
0.95
Technical Analysis
SMA50:
447.46
SMA100:
460.60
SMA200:
456.84
52-Wk Change:
-2.71%
Stock Predictions
-
Is Vertex Pharmaceuticals stock public?Yes, Vertex Pharmaceuticals is a publicly traded company.
-
What is the Vertex Pharmaceuticals stock quote today?The Vertex Pharmaceuticals stock price is 422.00 USD today.
-
How to buy Vertex Pharmaceuticals stock online?You can buy Vertex Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-27 | 405.26 | 408.76 | 410.98 | 404.49 |
| Dec-30 | 404.54 | 399.35 | 407.35 | 399.06 |
| Dec-31 | 399.63 | 402.70 | 404.99 | 399.63 |
| Jan-2 | 403.14 | 405.76 | 409.60 | 402.72 |
| Jan-3 | 407.57 | 407.11 | 411.65 | 406.40 |
| Jan-6 | 401.31 | 402.49 | 404.74 | 399.00 |
| Jan-7 | 403.00 | 408.32 | 410.81 | 401.54 |
| Jan-8 | 410.71 | 412.11 | 412.36 | 407.24 |
| Jan-10 | 406.17 | 409.56 | 413.52 | 405.17 |
| Jan-13 | 408.00 | 413.37 | 416.55 | 397.25 |
| Jan-14 | 411.94 | 411.66 | 414.50 | 408.02 |
| Jan-15 | 415.13 | 424.26 | 425.49 | 415.13 |
| Jan-16 | 423.41 | 416.96 | 424.58 | 415.15 |
| Jan-17 | 422.73 | 422.00 | 428.25 | 419.27 |
Vertex Pharmaceuticals Earnings
Vertex Pharmaceuticals Earnings Report: Per Share Vertex Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Vertex Pharmaceuticals Forecast Revenue Growth
Vertex Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Vertex Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.51 per share, a decrease next quarter of $0.00 per share, an increase this year of $18.22 per share, and an increase next year of $2.05 per share.
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.